Clinical Trial Update: Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of Trabectedin for advanced rearranged mesenchymal chondrosarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesenchymal Chondrosarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Mesenchymal Chondrosarcoma | Phase 2 | Status: RECRUITING